Soursop leaves have a long history in tropical folk medicine, used primarily as a tea for relaxation, fever reduction, and inflammation. Modern lab research has identified dozens of bioactive compounds in the leaves, some with genuinely interesting effects on cancer cells, blood sugar, blood pressure, and bacteria in controlled studies. But the evidence comes almost entirely from test tubes and animal experiments, not human trials, and the leaves carry a real neurotoxicity risk that deserves attention before you brew a cup.
What Makes Soursop Leaves Biologically Active
Soursop leaves contain three major families of bioactive compounds: phenolics, alkaloids, and acetogenins. The phenolics include flavonoids, tannins, and acids like gallic acid, all of which act as antioxidants by neutralizing free radicals and reducing oxidative damage to cells. The alkaloids have shown pain-relieving and mood-related effects in lab settings. The acetogenins are the compounds that get the most scientific attention, particularly one called annonacin, the most abundant acetogenin in the leaves. Over 40 different acetogenins have been isolated from soursop leaves alone.
These compounds don’t just sit in the leaf passively. Catechins in the leaves can damage bacterial cell membranes, causing them to rupture. Gallic acid triggers oxidative stress specifically in tumor cells that lack certain protective enzymes. Acetogenins shut down energy production inside cells by blocking a key step in the mitochondria. This is what makes soursop leaves both promising and potentially dangerous, depending on which cells are being affected.
Blood Sugar and Cholesterol
A 2025 meta-analysis that pooled results from multiple animal studies found soursop extract significantly reduced blood glucose levels in diabetic rats compared to untreated controls. The blood sugar-lowering effect was consistent across studies and appeared strong.
In a separate animal study published in Frontiers in Nutrition, soursop leaf extract reduced triglycerides, total cholesterol, LDL (“bad” cholesterol), and several markers used to estimate heart disease risk in rats with induced high blood pressure. The extract also lowered blood pressure itself. These changes happened in a dose-dependent way, meaning higher doses produced larger effects. The researchers attributed the cardiovascular benefits partly to the leaves’ ability to reduce inflammation and oxidative stress, measured by lower levels of inflammatory signaling molecules and restored levels of the body’s own protective antioxidant enzymes.
None of this has been confirmed in human trials. Animal metabolisms differ from ours, and doses used in these studies don’t translate directly to cups of tea.
Antibacterial and Antifungal Effects
Soursop leaf extract has shown activity against drug-resistant strains of Candida albicans, a fungus responsible for common yeast infections and more serious systemic infections in immunocompromised people. In lab testing, the extract worked against strains that had already developed resistance to multiple standard antifungal medications. Researchers found the extract attacked the outer envelope of the fungal cells, suggesting a different mechanism than conventional drugs.
The antibacterial activity is linked mainly to catechins in the leaves, which bind to bacterial cell membranes and physically burst them open. This has been demonstrated in vitro, but again, killing bacteria in a petri dish is a much lower bar than treating an infection in a living person.
Cancer Research: Lab Promise, No Human Proof
Acetogenins from soursop leaves have killed cancer cells from breast, prostate, liver, colorectal, and other tumor lines in laboratory settings. The mechanism involves starving cancer cells of energy by blocking their mitochondria. Gallic acid in the leaves adds a second pathway, triggering oxidative damage that healthy cells can handle but tumor cells often cannot.
Despite these results, no completed human clinical trial has shown soursop leaves treat cancer. A pilot study registered on ClinicalTrials.gov attempted to test soursop leaf tea in patients with several types of advanced cancer, including stomach, liver, pancreatic, and colorectal cancers. The trial’s own description acknowledged that “no prospective clinical studies have been carried out to determine if it also has clinical activity.” The study’s status is listed as unknown, and no results were ever posted.
The FDA has taken enforcement action against companies marketing soursop products as cancer treatments. In a 2017 warning letter, the agency told a soursop seller that their capsules, tea bags, and dried leaves were being illegally marketed as drugs because of disease-treatment claims on their labels. Soursop is not approved by the FDA for the treatment or prevention of any disease.
The Neurotoxicity Concern
This is the part most soursop articles bury or skip, but it’s arguably the most important thing to know. Annonacin, the most abundant acetogenin in soursop leaves, is a potent neurotoxin. It kills dopamine-producing brain cells by shutting down their energy supply, and it’s roughly 700 times more toxic to neurons than rotenone, a pesticide that has itself been linked to Parkinson’s disease.
The strongest epidemiological signal comes from the Caribbean island of Guadeloupe, where soursop consumption is widespread. French researchers studying 160 patients with Parkinson’s-like symptoms on the island found that about one-third had a typical Parkinson’s presentation, but another two-thirds had atypical forms, including progressive supranuclear palsy and a parkinsonism-dementia complex. Soursop consumption was significantly higher in the patients with these atypical forms compared to both healthy controls and patients with standard Parkinson’s disease.
In animal studies, annonacin crossed into the brain, depleted cellular energy, and caused neurodegeneration in the movement-control regions. Chronic soursop consumption in mice triggered abnormal changes to tau protein in the brain, a hallmark of neurodegenerative diseases. These effects occurred even in normal (non-genetically modified) mice. The concern isn’t theoretical: the same tau protein changes are seen in Alzheimer’s disease and certain forms of dementia.
How People Typically Prepare It
Soursop leaf tea is the most common preparation. The traditional method is to simmer dried leaves for 10 to 15 minutes for a strong, earthy brew. A lighter version uses a 5 to 7 minute steep in hot water. Some people cold-steep the leaves overnight in room temperature or cold water for a milder flavor. A standard amount is 2 to 3 grams of dried leaves per 8-ounce cup.
People who drink soursop tea regularly typically consume 1 to 2 cups per day. There is no established safe dosage from any regulatory body, and given the neurotoxicity data, the “right” amount is genuinely unknown. The annonacin content varies between batches of leaves, growing regions, and preparation methods, which makes it impossible to know how much neurotoxin you’re actually getting in any given cup. Starting with small, infrequent amounts and avoiding daily long-term use is a reasonable precaution given what the research currently shows.